Bristol Myers Squibb gets EU approval for Sotyktu to treat psoriatic arthritis
Go back to Bristol Myers Squibb gets EU approval for Sotyktu to treat psoriatic arthritis| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 55.66 +0.96 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.70 | 52 Week High | $77.12 | |||
| Open | $55.39 | 52 Week Low | $49.03 | |||
| Day High | $55.69 | P/E | 36.14 | |||
| Day Low | $54.96 | EPS | $1.54 | |||
| Volume | 3,232,825 | |||||
